Neuromorphic vision sensing (NVS) hardware is now gaining traction as a low-power/high-speed visual sensing technology that circumvents the limitations of conventional active pixel sensing (APS) cameras. While object detection and tracking models have been investigated in conjunction with NVS, there is currently little work on NVS for higher-level semantic tasks, such as action recognition. Contrary to recent work that considers homogeneous transfer between flow domains (optical flow to motion vectors), we propose to embed an NVS emulator into a multi-modal transfer learning framework that carries out heterogeneous transfer from optical flow to NVS. The potential of our framework is showcased by the fact that, for the first time, our NVS-based results achieve comparable action recognition performance to motion-vector or opticalflow based methods (i.e., accuracy on UCF-101 within 8.8% of I3D with optical flow), with the NVS emulator and NVS camera hardware offering 3 to 6 orders of magnitude faster frame generation (respectively) compared to standard Brox optical flow. Beyond this significant advantage, our CNN processing is found to have the lowest total GFLOP count against all competing methods (up to 7.7 times complexity saving compared to I3D with optical flow).
Purpose of review:The purpose of this review is to describe the current status of automated deep learning in healthcare and to explore and detail the development of these models using commercially available platforms. We highlight key studies demonstrating the effectiveness of this technique and discuss current challenges and future directions of automated deep learning. Recent findings: There are several commercially-available automated deep learning platforms. While specific features differ between platforms, they utilise the common approach of supervised learning. Ophthalmology is an exemplar specialty in the area, with a number of recent proof-of-concept studies exploring classification of retinal fundus photographs, optical coherence tomography images and indocyanine green angiography images. Automated deep learning has also demonstrated impressive results in other specialties such as dermatology, radiology and histopathology. Summary: Automated deep learning allows users without coding expertise to develop deep learning algorithms. It is rapidly establishing itself as a valuable tool for those with limited technical experience. Despite residual challenges, it offers considerable potential in the future of patient management, clinical research and medical education.
Purpose Neovascular age-related macular degeneration (nAMD) is a major global cause of blindness. Whilst anti-vascular endothelial growth factor (anti-VEGF) treatment is effective, response varies considerably between individuals. Thus, patients face substantial uncertainty regarding their future ability to perform daily tasks. In this study, we evaluate the performance of an automated machine learning (AutoML) model which predicts visual acuity (VA) outcomes in patients receiving treatment for nAMD, in comparison to a manually coded model built using the same dataset. Furthermore, we evaluate model performance across ethnic groups and analyse how the models reach their predictions. Methods Binary classification models were trained to predict whether patients’ VA would be ‘Above’ or ‘Below’ a score of 70 one year after initiating treatment, measured using the Early Treatment Diabetic Retinopathy Study (ETDRS) chart. The AutoML model was built using the Google Cloud Platform, whilst the bespoke model was trained using an XGBoost framework. Models were compared and analysed using the What-if Tool (WIT), a novel model-agnostic interpretability tool. Results Our study included 1631 eyes from patients attending Moorfields Eye Hospital. The AutoML model (area under the curve [AUC], 0.849) achieved a highly similar performance to the XGBoost model (AUC, 0.847). Using the WIT, we found that the models over-predicted negative outcomes in Asian patients and performed worse in those with an ethnic category of Other. Baseline VA, age and ethnicity were the most important determinants of model predictions. Partial dependence plot analysis revealed a sigmoidal relationship between baseline VA and the probability of an outcome of ‘Above’. Conclusion We have described and validated an AutoML-WIT pipeline which enables clinicians with minimal coding skills to match the performance of a state-of-the-art algorithm and obtain explainable predictions.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.